InvestorsHub Logo
Followers 55
Posts 8812
Boards Moderated 0
Alias Born 12/01/2010

Re: None

Monday, 07/04/2022 11:39:04 AM

Monday, July 04, 2022 11:39:04 AM

Post# of 402953
Nasrat said WE are working several new drugs,, and ANDA's (WHOs WE ?) sucker, lol from dirty harry, , could it be KBP,

does anybody on this board know what mersa is, for Gods sake

they are working on a unique effect on Acinetobacter baumanni as well as Gram-positive bacterial strains such as MRSA, PRSP, and VRE. KBP-7072 has multiple regulatory incentives in place including Qualified Infectious Disease Product (QIDP) / Fast Track Designation from the U.S. FDA, which qualifies it for fast track approval, potential priority review, and an additional five years of exclusivity after approval.

Don't you think Robert Chen might, ok,, maybe, bring that new NDA to Elite, they need a manufacture to make the pill's, by the millions, if approved.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News